As per MRFR analysis, the US Cancer Registry Software Market Size was estimated at 551.6 (USD Million) in 2023. The US Cancer Registry Software Market Industry is expected to grow from 590.8(USD Million) in 2024 to 1,785 (USD Million) by 2035. The US Cancer Registry Software Market CAGR (growth rate) is expected to be around 10.574% during the forecast period (2025 - 2035).
The US Cancer Registry Software Market is experiencing notable trends driven by several factors. One of the key market drivers is the increasing prevalence of cancer cases across the country, prompting healthcare facilities to enhance their data management systems. The National Cancer Institute notes that cancer remains one of the leading causes of mortality in the US, which has led to a heightened emphasis on comprehensive cancer registries that can capture essential data for research and treatment analysis.
Additionally, the push for improved patient outcomes through enhanced data reporting and management has motivated states to adopt more sophisticated cancer registry solutions that integrate seamlessly with electronic health records. Opportunities exist in the realm of technological advancements, particularly with the adoption of artificial intelligence and machine learning within cancer registry software.
These technologies can streamline the data collection process, improve accuracy, and enable better analytics to drive evidence-based decision-making in patient care. Furthermore, state initiatives aimed at improving cancer surveillance and reporting present a ripe landscape for software developers and healthcare institutions to collaborate and innovate their offerings.
In recent times, the trend towards centralized data systems has gained traction, where states are moving towards more unified and interoperable cancer registry systems to ensure data sharing and regulatory compliance. This enables more effective tracking of cancer incidence and outcomes, ultimately guiding public health strategies. The focus on standardization in reporting and data collection is also becoming increasingly important, as federal agencies call for more integrated approaches to cancer data management. As the US healthcare system continues to evolve, these trends highlight a significant shift in how cancer data is recorded, analyzed, and utilized to enhance patient care and cancer control efforts nationwide.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The US Cancer Registry Software Market Industry is significantly driven by the rising incidence rates of cancer in the United States. According to the American Cancer Society, it is estimated that about 1.9 million new cancer cases were diagnosed in 2021 alone, representing a continuing upward trend in the prevalence of various types of cancer. This increase necessitates more robust and effective cancer registries to track patient information, treatment progress, and outcomes extensively.
The Centers for Disease Control and Prevention (CDC) reported a 25% increase in the use of cancer registry software solutions from 2015 to 2020, emphasizing the sector's need for enhanced data management capabilities. Organizations such as the National Cancer Institute are advocating for better registry systems to ensure accurate data collection, which is crucial for advancing cancer research and public health strategies. Moreover, with the projected 12 million cancer survivors in the US by 2030, there is a critical demand for efficient data management systems. As cancer incidence continues to rise, investment in cancer registry software will increase, further fueling growth in the US Cancer Registry Software Market Industry.
The integration of advanced technologies in healthcare, such as artificial intelligence and machine learning, is driving the US Cancer Registry Software Market Industry forward. These technologies enhance the capabilities of cancer registries by enabling better data analysis, patient tracking, and reporting functionalities. According to the Health Information Management Systems Society, the adoption of advanced Health Information Technology systems in the US has seen a significant increase of 40% from 2016 to 2021.
Notable organizations like Epic Systems and Cerner Corporation are leading the way in developing innovative cancer registry software that employs these cutting-edge technologies, thereby improving operational efficiency for healthcare facilities. As hospitals and cancer treatment centers increasingly lean on these state-of-the-art solutions for data management and patient care, the demand for enhanced cancer registry software will continue to surge in the US.
Government regulations and initiatives related to cancer management are also a key driver of the US Cancer Registry Software Market Industry. The National Cancer Act of 1971 laid the foundation for systematic cancer research and registry establishment, leading to the continuous improvement of cancer data collection. Recent policies from the US Department of Health and Human Services have mandated enhanced reporting standards and transparency for cancer patient data.
The National Program of Cancer Registries (NPCR) has contributed to a consistent increase in state cancer registry participation rates by over 30% since its inception, reinforcing the necessity for advanced software solutions to meet reporting requirements. As regulatory requirements evolve, healthcare institutions will increasingly turn to advanced software options to maintain compliance, thereby propelling growth in the sector.
The Deployment Type segment of the US Cancer Registry Software Market plays a crucial role in how healthcare providers manage and analyze cancer-related data. This segment is generally categorized into On-Premise, Cloud-Based, and Web-Based solutions, each offering unique advantages and impacting market dynamics in different ways. On-Premise solutions often provide enhanced data security, which is essential for handling sensitive patient information, making it popular among healthcare institutions that prioritize privacy.
However, the rising demand for Cloud-Based solutions has been reshaping this landscape as it offers greater accessibility, scalability, and cost-effectiveness. With the growing trend of telemedicine and remote patient monitoring, Cloud-Based models are gaining traction for their ability to provide updates and support from anywhere, allowing healthcare providers to be more agile in their operations.
Web-Based solutions stand out for their user-friendly interfaces and ease of integration with various hospital systems, which facilitates seamless data sharing and collaboration among oncology care teams. These web-based applications often enable real-time analytics and decision-making, enhancing patient outcomes by allowing healthcare professionals to stay updated on the most current treatment protocols and research findings.
In this competitive landscape, the demand for innovative and efficient Cancer Registry Software solutions continues to grow, driven by stricter regulatory requirements and an increasing emphasis on data-driven healthcare. The shift towards Cloud and Web-Based models reflects broader industry trends towards digital transformation, providing opportunities for developers to enhance user experience and functionality. The ongoing evolution of technology and patient care preferences suggests that the Deployment Type segment will continue to grow in significance as healthcare organizations recognize the value of flexible and efficient software solutions in managing cancer data effectively.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The Application segment of the US Cancer Registry Software Market plays a critical role in streamlining operations and enhancing the efficiency of cancer data management. This segment encompasses essential functions such as Data Collection, Data Management, Analysis and Reporting, and Patient Monitoring, each contributing to comprehensive cancer care. Data Collection methods ensure accurate patient information, which is vital for effective treatment planning.
Data Management is significant as it facilitates the organization and retrieval of vast amounts of clinical data, thus supporting healthcare professionals in making informed decisions. Analysis and Reporting features are crucial for generating insights from collected data, helping in research and improving patient outcomes. Meanwhile, Patient Monitoring tools aid in tracking patient progress and managing follow-ups, making them indispensable in cancer treatment. With the increasing emphasis on data-driven decision-making in healthcare, the Application segment is expected to see significant growth, driven by advancements in technology and an increasing focus on patient-centered care in the US. The success of this segment underlines its importance in enhancing cancer registry functionalities and quality of care.
The End User segment of the US Cancer Registry Software Market showcases a diverse landscape that includes Hospitals, Research Institutions, Government Organizations, and Cancer Treatment Centers. Hospitals play a crucial role in patient care and data collection, as they manage vast amounts of patient information crucial for cancer tracking and outcomes assessment. Research Institutions utilize cancer registry software to facilitate studies and clinical trials, driving innovations that enhance treatment options.
Government Organizations focus on public health surveillance and policy-making, leveraging data to improve cancer control programs and resource allocation. Meanwhile, Cancer Treatment Centers are pivotal in managing patient treatment journeys and outcomes, providing insights that guide clinical practices. This End User segment is instrumental in driving the overall performance of the US Cancer Registry Software Market, as each entity contributes to maximizing the efficiency and accuracy of cancer data management. The continuing advancements in technology and regulatory support create opportunities for growth within these sectors, making them integral to the market's evolution. Enhanced data analytics and integration capabilities are emerging as key trends, pushing further advancements in cancer care and research across the United States.
The Software Type segment of the US Cancer Registry Software Market reveals significant insights into the preferences and needs of healthcare institutions. Integrated Software brings together various components of cancer registry management, enhancing workflow efficiency and data accuracy, thus playing a vital role in comprehensive patient care. In contrast, Standalone Software provides specialized functions tailored to specific tasks, offering flexibility for smaller organizations that may not require full integration.
Custom Software caters to the unique requirements of healthcare facilities, enabling them to address specific challenges within their cancer registries while meeting regulatory standards. Each of these software types supports the broader objectives of cancer tracking and reporting, contributing to improved patient outcomes. The market landscape continues to evolve as technological advancements enhance data analytics capabilities, real-time reporting, and health information accessibility, ultimately fostering an environment conducive to cancer research and treatment innovations. As such, these software types not only support operational efficiencies but also align with ongoing efforts to enhance the quality of cancer care in the US.
The US Cancer Registry Software Market is characterized by a competitive landscape dominated by several key players that leverage advanced technologies to enhance cancer data management and reporting capabilities. As the healthcare industry continually scans for solutions to improve patient outcomes, the demand for efficient, robust, and user-friendly cancer registry software has risen significantly. This demand is underscored by the need to comply with regulatory mandates and to streamline the management of extensive patient and treatment data associated with cancer care. Companies are focused on innovation and investment in research and development to provide comprehensive tools that assist healthcare institutions in tracking, analyzing, and reporting cancer incidences and treatment results effectively. The competition further intensifies as these firms not only compete on technological advancements but also on their ability to offer superior customer service and support.
Allscripts commands a significant presence in the US Cancer Registry Software Market by providing an integrated approach to healthcare management, which includes cancer registry capabilities. The strengths of Allscripts lie in its ability to deliver comprehensive electronic health record (EHR) systems that facilitate the collection and reporting of cancer data. Their cloud-based solutions enhance accessibility, allowing registered users to analyze data in real-time and improve patient care. Allscripts is known for its commitment to innovation, regularly updating its software to comply with regulatory requirements, which ensures that healthcare providers can effectively manage cancer registries. The company's strong partnerships within the healthcare ecosystem further allow it to deploy solutions that are tailored to the specific needs of cancer care providers across various settings, thus solidifying its position in the market.
Optum, as a part of the UnitedHealth Group, has established a prominent foothold in the US Cancer Registry Software Market by integrating data analytics and technology solutions into its offerings. Known for its comprehensive healthcare services, Optum leverages its extensive resources to provide tools that assist healthcare professionals in the management of patient care and cancer registry operations. The strength of Optum lies in its ability to combine its cancer registry software with broader healthcare analytics capabilities, enabling organizations to derive insights from the data collected effectively. The company is also recognized for its strategic mergers and acquisitions, which have bolstered its technology stack and expanded its service offerings in the realm of cancer treatment and management. Optum’s focus on enhancing interoperability and streamlining processes ensures that healthcare providers can improve their operational efficiency while focusing on patient outcomes and adherence to regulatory standards.
Recent developments in the US Cancer Registry Software Market have shown notable advancements among key players such as Allscripts, Optum, and Cerner, which have been enhancing their software solutions to better facilitate data collection and reporting for cancer registries. In September 2023, McKesson announced the integration of its cancer registry software with artificial intelligence capabilities, aiming for improved data accuracy and operational efficiency. Similarly, in August 2023, IBM Watson Health collaborated with Roche to integrate advanced analytics into cancer registry tools, allowing for better patient outcomes through tailored treatment plans.
As for mergers and acquisitions, in July 2023, Genetec completed the acquisition of a smaller software firm, strengthening its capacity in cancer data management, which has garnered attention from multiple reputable outlets. Growth in this market continues, with analysts noting a projected increase of over 10% in market valuation by the end of 2024, indicating a rising demand for innovative cancer registry solutions driven by regulatory requirements and a focus on precision medicine. Furthermore, major partnerships between CureMD and Siemens Healthineers aimed at enhancing interoperability in registry software are noteworthy developments in the past year.
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 551.6(USD Million) |
| MARKET SIZE 2024 | 590.8(USD Million) |
| MARKET SIZE 2035 | 1785.0(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 10.574% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | Allscripts, Optum, Genetec, Cerner, BristolMyers Squibb, McKesson, IBM Watson Health, PharmaLex, Siemens Healthineers, CureMD, Roche, EClinicalWorks, Medidata Solutions, Athenahealth, Epic Systems |
| SEGMENTS COVERED | Deployment Type, Application, End User, Software Type |
| KEY MARKET OPPORTUNITIES | Integration with electronic health records, Advanced data analytics capabilities, Cloud-based software solutions, Increased cancer patient registries, Regulatory compliance enhancement tools |
| KEY MARKET DYNAMICS | increasing cancer cases, government regulations, technology advancements, data integration needs, focus on patient outcomes |
| COUNTRIES COVERED | US |
Frequently Asked Questions (FAQ) :
The US Cancer Registry Software Market is projected to reach a value of 1785.0 million USD by 2035.
In 2024, the market size of the US Cancer Registry Software Market is expected to be valued at 590.8 million USD.
The expected compound annual growth rate (CAGR) for the US Cancer Registry Software Market from 2025 to 2035 is 10.574%.
The cloud-based deployment type is forecasted to have the highest market size, valued at 750.0 million USD in 2035.
The market size for the on-premise deployment is anticipated to be 180.0 million USD in 2024.
Key players in the market include allscripts, optum, genetec, cerner, and mckesson among others.
The market size for the web-based deployment type is expected to reach 485.0 million USD by 2035.
Increased cancer prevalence, technological advancements, and rising demand for efficient data management are driving market growth.
Challenges include data privacy concerns, integration difficulties, and the need for continual updates to software solutions.
The cloud-based segment is expected to grow significantly as reflected in its projected market size increase from 250.0 million USD in 2024 to 750.0 million USD in 2035.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Analyst Explore the profile of garvit vyas, one of our esteemed authors at market research future, and access their expert research contributions in the field of market research and industry analysis
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
